Back
Fulcrum Therapeutics Vs. Belite Bio Industry Stock Comparison
Sell
11
FULC
Fulcrum Therapeutics
Last Price:
$3.60
Seasonality Move:
-24.8%
Sell
35
BLTE
Belite Bio
Last Price:
$57.65
Seasonality Move:
-14.78%
Sell
11
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
-
The current Fulcrum Therapeutics [FULC] share price is $3.59. The Score for FULC is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
FULC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Belite Bio (BLTE)
is a Sell
Is Belite Bio a Buy, Sell or Hold?
-
The current Belite Bio [BLTE] share price is $57.28. The Score for BLTE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
BLTE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $57.28The current trend is relatively stagnant and BLTE is experiencing buying pressure, which is a positive indicator for future bullish movement.
FULC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 43.28 | Sell |
Chaikin Money Flow: | 315093 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.56 - 4.04) | Sell |
Bollinger Bands (100): | (3.33 - 4.29) | Sell |
BLTE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 49.53 | Sell |
Chaikin Money Flow: | 36225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.88 - 58.6) | Buy |
Bollinger Bands (100): | (54.3 - 71.74) | Sell |
FULC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.66 | Sell |
20-day SMA: | 3.73 | Sell |
50-day SMA: | 4.12 | Sell |
200-day SMA: | 5.6 | Sell |
8-day EMA: | 3.6 | Sell |
20-day EMA: | 3.74 | Sell |
50-day EMA: | 3.93 | Sell |
200-day EMA: | 5.07 | Sell |
BLTE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.64 | Buy |
20-day SMA: | 56.98 | Buy |
50-day SMA: | 58.64 | Sell |
200-day SMA: | 55.49 | Buy |
8-day EMA: | 56.68 | Buy |
20-day EMA: | 57 | Buy |
50-day EMA: | 58.84 | Sell |
200-day EMA: | 55.58 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and an increase next year of $0.07 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.65 per share.
Fulcrum Therapeutics Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Belite Bio Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |